From: Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy
 | All patients N = 96 |
---|---|
n (percent, %) or median [interquartile range] or mean ± standard deviation | |
Procedural details | |
 Operative time (minutes) | 360.0 [325.0–420.0] |
 Estimated blood loss (liters) | 0.10 [0.05–0.20] |
 Intraoperative fluid replacement (liters) | 2.75 [2.25–3.50] |
 Urine output (liters) | 0.41 [0.30–0.60] |
 Conversion to open thoracotomy | 4 (4) |
Total hospital length of stay | |
 Index admission length of stay (days) | 8.0 [7.0–10.0] |
Postoperative adverse events during index admission | |
 Reoperation | 5 (5) |
 Clavien-Dindo major complications | 18 (19) |
  Anastomotic leak | 5 (5) |
  Graft necrosis | 1 (1) |
  Conduit volvulus/redundancy/obstruction | 4 (4) |
  Respiratory failure requiring intubation | 5 (5) |
  Atrial fibrillation requiring cardioversion | 3 (3) |
  In-hospital mortality | 1 (1) |
 Clavien-Dindo minor complications | 27 (28) |
  Atrial fibrillation | 14 (15) |
  Ventricular tachycardia | 1 (1) |
  Respiratory insufficiency | 1 (1) |
  Pneumonia | 1 (1) |
  Pleural effusion | 2 (2) |
  Pneumothorax | 1 (1) |
  Ileus | 1 (1) |
  Colonic pseudo-obstruction | 1 (1) |
  Clostridium difficile infection | 2 (2) |
  Bacteremia | 1 (1) |
  Urinary retention | 1 (1) |
  Acute kidney injury | 1 (1) |
30-day adverse events | |
 30-day mortality | 2 (2) |
 30-day readmissions | 7 (7) |
 30-day reoperations | 7 (7) |
90-day adverse events | |
 90-day mortality | 3 (3) |
 90-day readmissions | 8 (8) |
 90-day reoperations | 8 (8) |